e-6599 Health
Petition to the House of Commons in Parliament assembled
Whereas:
Cluster headaches are one of the most excruciating conditions known to medicine, sometimes called "suicide headaches" due to the unbearable suffering they inflict;
Studies and case reports indicate that the psychedelic compounds psilocybin and DMT can abort or prevent cluster headache attacks with rapid onset and minimal physiological risk; and
These substances remain inaccessible to Canadians suffering from cluster headaches, despite their safety profile and lack of viable alternatives.
We, the undersigned, citizens and residents of Canada, call upon the Government of Canada to: 1. Draw the attention of the House of Commons to the urgent and ongoing suffering caused by cluster headaches, and the compelling clinical evidence supporting the use of psilocybin and N,N-Dimethyltryptamine (DMT) as potential treatments.to legalize or authorize physician-guided access to psilocybin and N,N-Dimethyltryptamine (DMT) for patients suffering from cluster headaches; and 2. Implement or expand regulatory pathways (such as Section 56 exemptions or Special Access Programs) to allow compassionate medical use of these compounds for this specific condition.
Whereas:
Cluster headaches are one of the most excruciating conditions known to medicine, sometimes called "suicide headaches" due to the unbearable suffering they inflict;
Studies and case reports indicate that the psychedelic compounds psilocybin and DMT can abort or prevent cluster headache attacks with rapid onset and minimal physiological risk; and
These substances remain inaccessible to Canadians suffering from cluster headaches, despite their safety profile and lack of viable alternatives.
We, the undersigned, citizens and residents of Canada, call upon the Government of Canada to: 1. Draw the attention of the House of Commons to the urgent and ongoing suffering caused by cluster headaches, and the compelling clinical evidence supporting the use of psilocybin and N,N-Dimethyltryptamine (DMT) as potential treatments.to legalize or authorize physician-guided access to psilocybin and N,N-Dimethyltryptamine (DMT) for patients suffering from cluster headaches; and 2. Implement or expand regulatory pathways (such as Section 56 exemptions or Special Access Programs) to allow compassionate medical use of these compounds for this specific condition.